Adeoye Y. Olukotun

This profile gathers the share dealings of Adeoye Y. Olukotun across 2 companies, led by Arrowhead Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. We count 15 filings; the first trade dates from 13 September 2021 and the latest from 18 August 2026.

Sales make up the whole of the open-market record (9 sales, €1.4M). Outside the open market, there are 5 share grants. 2026 to date brings no purchases and 1 sale.

The newest entry dates from 20 August 2026: an open-market sale of €150k, in Arrowhead Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.